Diabetes

Reducing diabetics' hypoglycaemic events

Insulin pumps that can respond to blood glucose concentration can reduce the rate of severe hypoglycaemia (low blood glucose) in type 1 diabetics, according to the results of a recent trial.

Oncology & Cancer

A better pump for pediatric brain cancer

Treating pediatric brain cancer can be a challenge, since the brain has ways to protect itself from drugs taken orally or intravenously. One solution to this frustrating problem: A miniature, implantable infusion pump no ...

Cardiology

Heart surgeons see innovations with tiny new pumps

A new generation of cardiac devices scheduled for human trials in Europe and the United States next year has heart surgeons talking about a possible sea change in the treatment of patients suffering from the most severe level ...

Oncology & Cancer

Team uncovers pathway linking heartburn and esophageal cancer

Got heartburn? More than 60 million adults in the U.S. have acid reflux, or heartburn, and approximately 10 percent are at risk for developing esophageal cancer, due in part to complications from Barrett's esophagus. But ...

Cardiology

Study: Heart pump with behind-the-ear power connector

Cardiac surgeons and cardiologists at the University of Maryland Heart Center are part of a multi-center clinical trial evaluating the efficacy of powering heart pumps through a skull-based connector behind the ear. Typically, ...

Cardiology

Acid reflux drug may cause heart disease

(Medical Xpress)—Drugs that help millions of people cope with acid reflux may also cause cardiovascular disease, report scientists from Houston Methodist Hospital and two other institutions in an upcoming issue of Circulation. ...

Medical research

Researcher studies protein's link to heart disease

(Medical Xpress)—The largest protein known to exist in the human body functions as a molecular spring, and University of Arizona researchers are gaining new insights into its role in heart disease.

Diseases, Conditions, Syndromes

Duloxetine moderately cost-effective for treating back pain

(HealthDay)—Duloxetine is a moderately cost-effective treatment for chronic low back pain (CLBP) compared with other post-first-line oral medications, according to research published in the May 15 issue of Spine.

page 25 from 39